May your protocols stay evidence-based, your side effects stay manageable, and your results stay beyond expectations.
In particular, the observed changes in MAPK- and Rap1-related pathways are biologically plausible, given their established roles in inflammatory signaling and epithelial junction regulation, respectively [59, 71, 72]
A 12-week phase II placebo-controlled clinical trial with 255 patients with type 2 diabetes receiving KBP-042 has been completed (156), but further development of KBP-042 has been terminated by Eli Lilly and Nordic Bioscience to focus on the development of KBP-089, which is reportedly superior to KBP-042 (157, 158)
Li L, Li T, Qu X, Sun G, Fu Q, Han G
They work together to create an integrated cellular health strategy - NAD+ helps produce energy while glutathione handles the waste products
It takes some help with glutathione to kind of do the work for liver until the liver gets healthy, but in 12 to 15 months, you can literally improve your liver health to go back to normal as best as possible again, which is essential for long term health
